COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study evaluates the benefit of colchicine on induced denervation after myocardial infarction. Patients who have suffered a documented De Novo myocardial infarction and completed a revascularization procedure will receive either colchicine on top of standard therapy, compared to standard therapy alone (1:1 allocation ratio). Colchicine 1mg (or 0.5mg) will be initiated within 48h after percutaneous revascularization and prescribed for one month.
Epistemonikos ID: 44661e4d1888c4b445f91ca8a0852aa9e4d9ae30
First added on: May 07, 2024